1,3-beta-D-glucan synthase complex (GS)

The 1,3-beta-D-glucan synthase complex is a vital multi-subunit enzyme located in the fungal plasma membrane that is responsible for the synthesis of 1,3-beta-D-glucan, the major structural polysaccharide of the fungal cell wall [1, 4]. It typically consists of a large catalytic subunit, such as Fks1p or Fks2p, and a regulatory subunit, Rho1p, which is a small GTPase that activates the enzyme in a GTP-dependent manner [1, 14]. This complex is a critical therapeutic target because 1,3-beta-D-glucan is essential for maintaining the mechanical strength and osmotic stability of the fungal cell, yet the enzyme is absent in mammalian cells, providing high drug selectivity [2, 7]. Antifungal agents such as echinocandins (e.g., caspofungin, micafungin) and triterpenoids (e.g., ibrexafungerp) target this complex by non-competitively inhibiting the catalytic subunit, leading to cell wall depletion and osmotic lysis [5, 10]. Clinical resistance is primarily mediated by mutations in highly conserved hot-spot regions of the FKS subunits, which significantly reduce the binding affinity of these inhibitors [11, 13]. Monitoring of serum (1,3)-beta-D-glucan levels serves as a key biomarker for diagnosing invasive fungal infections and assessing the efficacy of treatments targeting this complex [21].

Other names

1,3-beta-D-glucan synthaseBeta-(1,3)-glucan synthaseFks1p/Rho1p complexGlucan synthase complexUDP-glucose 1,3-beta-D-glucan beta-D-glucosyltransferaseCallose synthaseGS-II

Non-competitive inhibition of 1,3-beta-D-glucan synthesis by binding to the catalytic Fks subunit, leading to depletion of cell wall glucans and osmotic lysis.